Journal profile · CLINICAL NEUROLOGY
Future Neurology
ISSN 1479-6708 · eISSN 1748-6971 · Future Medicine Ltd.
Future Neurology: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; median 100 days to acceptance (36 articles, last 24 months); 18 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Future Neurology is published by Future Medicine Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research and Neuroinflammation and Neurodegeneration Mechanisms, together about 26.6% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): CLINICAL NEUROLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Alzheimer's disease research and treatmentsMedicine10.8%
- Dementia and Cognitive Impairment ResearchMedicine9.4%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience6.4%
- Parkinson's Disease Mechanisms and TreatmentsMedicine5.6%
- Acute Ischemic Stroke ManagementMedicine4.9%
- Neuroscience and Neuropharmacology ResearchNeuroscience4.9%
- Multiple Sclerosis Research StudiesMedicine4.8%
- Epilepsy research and treatmentMedicine4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Neurology (clinical) | Q4 | 348/403 | 13th |
| Neurology | Q4 | 179/201 | 11th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.6LetPub ·
- SJR 2026-06
- 0.16LetPub ·
- SNIP 2026-06
- 0.23LetPub ·
- h-index
- 45OpenAlex ·
- i10-index
- 208OpenAlex ·
- 2-year mean citedness
- 0.67OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 5LetPub ·
Articles by year OpenAlex count · 1,030 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 19 | 19 | 330 |
| 2025 | 18 | 18 | 514 |
| 2024 | 11 | 11 | 508 |
| 2023 | 10 | 10 | 570 |
| 2022 | 9 | 9 | 650 |
| 2021 | 2 | 2 | 732 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
100 daysMedian, submission to acceptance · P25–P75 71 days – 188 days
- Acceptance to online
- median 25 days (36 articles)
- Submission to online
- median 125 days
- Sample
- 36 articles with submission and acceptance dates (37 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Future Medicine Ltd.
- ISSN
- 1479-6708
- Electronic ISSN
- 1748-6971
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Future Neurology
What CAS zone is Future Neurology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Future Neurology is in Zone 4 of Medicine, and in Zone 4 of the minor category Clinical Neurology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Future Neurology?
Based on the dates recorded on 36 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 100 days (interquartile range 71–188 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Future Neurology?
According to LetPub and DOAJ records, Future Neurology is indexed in ESCI and Scopus.
Is Future Neurology open access, and what is the APC?
Future Neurology is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .